Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.

van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):880-90. doi: 10.1002/pds.1782.

PMID:
19593747
2.

Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.

van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM.

Value Health. 2009 Sep;12(6):909-14. doi: 10.1111/j.1524-4733.2009.00506.x. Epub 2009 Mar 11.

PMID:
19508664
3.

Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands.

van der Linden MW, Penning-van Beest FJ, Nijsten T, Herings RM.

Drug Saf. 2009;32(6):527-37. doi: 10.2165/00002018-200932060-00008.

PMID:
19459719
4.

Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in The Netherlands.

Van der Linden MW, Gaugris S, Kuipers EJ, Van den Bemt BJ, van Herk-Sukel MP, Herings RM.

Curr Med Res Opin. 2009 Jan;25(1):195-204. doi: 10.1185/03007990802632915 .

PMID:
19210152
5.

LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results.

Heintjes EM, Hirsch MW, van der Linden MW, O'Donnell JC, Stalenhoef AF, Herings RM.

Curr Med Res Opin. 2008 Aug;24(8):2241-50. doi: 10.1185/03007990802264487. Epub 2008 Jun 24.

PMID:
18578957
6.

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.

van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM.

Ann Rheum Dis. 2009 May;68(5):668-73. doi: 10.1136/ard.2007.087254. Epub 2008 May 21.

PMID:
18495734
7.

Self-reported prevalence of warts in children and GP consultation.

Mohammedamin RS, van der Wouden JC, Koning S, van der Linden MW, Schellevis FG, van Suijlekom-Smit LW, Koes BW.

Eur J Gen Pract. 2008;14(1):34-6. doi: 10.1080/13814780701855716. No abstract available.

PMID:
18464171
8.

Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.

Sukel MP, van der Linden MW, Chen C, Erkens JA, Herings RM.

Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):9-19.

PMID:
17963198
9.

Development of a case-based system for grouping diagnoses in general practice.

Biermans MC, de Bakker DH, Verheij RA, Gravestein JV, van der Linden MW, Robbé PF.

Int J Med Inform. 2008 Jul;77(7):431-9. Epub 2007 Sep 17.

PMID:
17870659
10.

Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.

Niermeijer JM, Eurelings M, van der Linden MW, Lokhorst HM, Franssen H, Fischer K, Teunissen LL, van den Berg LH, Schobben F, Wokke JH, Notermans NC.

Neurology. 2007 Jul 3;69(1):50-9.

PMID:
17606880
11.

The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population.

Sutedja NA, Sinke RJ, Van Vught PW, Van der Linden MW, Wokke JH, Van Duijn CM, Njajou OT, Van der Schouw YT, Veldink JH, Van den Berg LH.

Arch Neurol. 2007 Jan;64(1):63-7.

PMID:
17210810
12.

Increasing incidence of skin disorders in children? A comparison between 1987 and 2001.

Mohammedamin RS, van der Wouden JC, Koning S, van der Linden MW, Schellevis FG, van Suijlekom-Smit LW, Koes BW.

BMC Dermatol. 2006 Mar 21;6:4.

13.

Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference?

Mohangoo AD, van der Linden MW, Schellevis FG, Raat H.

Eur J Public Health. 2006 Feb;16(1):101-5. Epub 2005 Sep 1.

14.

The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter.

Dijstelbloem HM, Hepkema BG, Kallenberg CG, van der Linden MW, Keijsers V, Huizinga TW, Jansen MD, van de Winkel JG.

Arthritis Rheum. 2002 Apr;46(4):1125-6. No abstract available.

PMID:
11953994
15.

Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease.

van der Pol WL, Huizinga TW, Vidarsson G, van der Linden MW, Jansen MD, Keijsers V, de Straat FG, Westerdaal NA, de Winkel JG, Westendorp RG.

J Infect Dis. 2001 Dec 15;184(12):1548-55. Epub 2001 Dec 3.

16.

Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus.

van der Linden MW, van der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GM, Westendorp RG, Huizinga TW.

Genes Immun. 2001 Nov;2(7):373-80.

17.

Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.

van der Linden MW, Westendorp RG, Zidane M, Meheus L, Huizinga TW.

J Rheumatol. 2001 Feb;28(2):284-7.

PMID:
11246662
18.

Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives.

van der Linden MW, van Lopik T, Aarden LA, Westendorp RG, Huizinga TW.

Ann Rheum Dis. 2001 Mar;60(3):237-41.

19.

High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.

van der Linden MW, Westendorp RG, Sturk A, Bergman W, Huizinga TW.

J Investig Med. 2000 Sep;48(5):327-34.

PMID:
10979237
20.

TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.

Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW.

Arthritis Rheum. 2000 Jan;43(1):129-34.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk